Dr. Olugbemisola Obi, MD

Claim this profile

University of Missouri Healthcare

Studies Respiratory Distress Syndrome
Studies Premature Birth
1 reported clinical trial
1 drug studied

Affiliated Hospitals

Image of trial facility.
University Of Missouri Health Care

Clinical Trials Olugbemisola Obi, MD is currently running

Image of trial facility.

PAL to Improve Oral Feeding

for Infants With Chronic Lung Disease

The purpose of this study is to investigate the effects of the Pacifier Activated Lullaby (PAL) intervention on the transition to oral feeding for preterm infants with chronic lung disease and respiratory distress syndrome that require non-invasive respiratory support at 34 weeks PMA. This study will utilize a clinical trial design. Participants will be randomized into two groups. One group will receive the PAL intervention, the other group serving as a no contact control. Participants will be matched based on sex, gestational age at birth, and neurologic injury. Infants in the intervention group will receive two PAL sessions a week until successfully transitioned to \<2L of respiratory support and then receive one PAL session within 24 hours of their first oral feeding attempt.
Recruiting1 award N/A5 criteria

More about Olugbemisola Obi, MD

Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Olugbemisola Obi, MD has experience with
  • Pacifier Activated Lullaby (PAL) Intervention
Breakdown of trials Olugbemisola Obi, MD has run
Respiratory Distress Syndrome
Premature Birth
Lung Disease
Neonatal Respiratory Distress Syndrome
Bronchopulmonary Dysplasia

Other Doctors you might be interested in

Savannah Davis, MDUniversity of Missouri Healthcare
Richard Ma, MDUniversity of Missouri Healthcare
Ellyn H Evans, Ph.D.University of Missouri Healthcare

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Olugbemisola Obi, MD specialize in?
Olugbemisola Obi, MD focuses on Respiratory Distress Syndrome and Premature Birth. In particular, much of their work with Respiratory Distress Syndrome has involved treating patients, or patients who are undergoing treatment.
Is Olugbemisola Obi, MD currently recruiting for clinical trials?
Yes, Olugbemisola Obi, MD is currently recruiting for 1 clinical trial in Columbia Missouri. If you're interested in participating, you should apply.
Are there any treatments that Olugbemisola Obi, MD has studied deeply?
Yes, Olugbemisola Obi, MD has studied treatments such as Pacifier Activated Lullaby (PAL) intervention.
What is the best way to schedule an appointment with Olugbemisola Obi, MD?
Apply for one of the trials that Olugbemisola Obi, MD is conducting.
What is the office address of Olugbemisola Obi, MD?
The office of Olugbemisola Obi, MD is located at: University of Missouri Healthcare, Columbia, Missouri 65212 United States. This is the address for their practice at the University of Missouri Healthcare.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top